Artivion
AORT • NYSE
Artivion is a medical - devices company in the healthcare sector trading on NYSE, led by CEO James Patrick Mackin, with a market cap of $1.9B.
CEOJames Patrick Mackin
Market Cap$1.9B
Medical - Devices
Healthcare
Employees1.5K
Websiteartivion.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Artivion
Date
Monday, May 4, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.10
Revenue Estimate
$113.7M
Earnings History
Past 11 earnings reports for Artivion
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q3 2025 | $0.16Est: $0.15 | +6.7% | $113.4MEst: $110.9M | +2.2% |  10-Q |
| Aug 7, 2025 | Q2 2025 | $0.24Est: $0.12 | +100.0% | $113.0MEst: $108.1M | +4.5% | 10-Q |
| May 5, 2025 | Q1 2025 | $0.06Est: $0.05 | +20.0% | $99.0MEst: $94.8M | +4.4% | 10-Q |
| Feb 24, 2025 | Q4 2024 | $0.00Est: $0.04 | -100.0% | $97.3MEst: $100.8M | -3.5% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.12Est: -$0.06 | +300.0% | $95.8MEst: $94.8M | +1.1% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.07Est: -$0.06 | +216.7% | $98.0MEst: $97.7M | +0.4% | 10-Q |
| May 6, 2024 | Q1 2024 | $0.06Est: -$0.12 | +150.0% | $97.4MEst: $92.0M | +5.9% | 10-Q |
| Feb 15, 2024 | Q4 2023 | $0.11Est: -$0.10 | +210.0% | $93.7MEst: $89.3M | +4.9% | 10-K |
| Nov 2, 2023 | Q3 2023 | $0.02Est: -$0.06 | +133.3% | $87.9MEst: $84.3M | +4.2% | — |
| Aug 3, 2023 | Q2 2023 | $0.06Est: -$0.08 | +175.0% | $89.3MEst: $84.2M | +5.9% | 10-Q |
| May 4, 2023 | Q1 2023 | $0.02Est: -$0.12 | +116.7% | $83.2MEst: $80.4M | +3.6% | 10-Q |